Advanced company searchLink opens in new window

BIODEXA PHARMACEUTICALS PLC

Company number 09216368

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
10 Sep 2019 TM02 Termination of appointment of Nicholas Robbins-Cherry as a secretary on 9 September 2019
07 Aug 2019 AP01 Appointment of Mr Frederic Duchesne as a director on 31 July 2019
23 Jul 2019 AA Group of companies' accounts made up to 31 December 2018
04 Jul 2019 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES09 ‐ Resolution of authority to purchase a number of shares
  • RES13 ‐ Company business 19/06/2019
18 Apr 2019 SH01 Statement of capital following an allotment of shares on 1 August 2018
  • GBP 2,146,999.165001
  • ANNOTATION Clarification a second filed SH01 was registered on 13/08/2020
18 Apr 2019 AP01 Appointment of Dr Huaizheng Peng as a director on 26 February 2019
18 Apr 2019 TM01 Termination of appointment of Pavlo Protopapa as a director on 26 February 2019
18 Apr 2019 TM01 Termination of appointment of Michele Luzi as a director on 26 February 2019
18 Apr 2019 TM01 Termination of appointment of John Joseph Johnston as a director on 26 February 2019
20 Mar 2019 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES13 ‐ Waiver granted by the panel on takeovers and mergers approved. 25/02/2019
  • RES10 ‐ Resolution of allotment of securities
19 Mar 2019 SH01 Statement of capital following an allotment of shares on 26 February 2019
  • GBP 2,146,999.100001
  • ANNOTATION Clarification a second filed SH01 was registered on 13/08/2020
28 Feb 2019 AD01 Registered office address changed from 65 Innovation Drive, Milton Park Milton Abingdon Oxfordshire OX14 4RQ to Oddfellows House 19 Newport Road Cardiff CF24 0AA on 28 February 2019
03 Dec 2018 MR04 Satisfaction of charge 092163680001 in full
16 Nov 2018 MR04 Satisfaction of charge 092163680004 in full
16 Nov 2018 MR04 Satisfaction of charge 092163680003 in full
06 Nov 2018 CS01 Confirmation statement made on 23 October 2018 with updates
  • ANNOTATION Clarification a second filed CS01 (Statement of capital change) was registered on 01/09/2020
06 Nov 2018 MR04 Satisfaction of charge 092163680002 in full
25 Oct 2018 RESOLUTIONS Resolutions
  • RES13 ‐ Sale agreement 15/10/2018
06 Aug 2018 AA Group of companies' accounts made up to 31 December 2017
14 Jun 2018 AP01 Appointment of Dr Craig Richard Cook as a director on 1 June 2018
14 Jun 2018 TM01 Termination of appointment of James Neil Phillips as a director on 31 May 2018
05 Feb 2018 SH01 Statement of capital following an allotment of shares on 7 November 2017
  • GBP 102,442.465401
  • ANNOTATION Clarification a second filed SH01 was registered on 13/08/2020
05 Feb 2018 SH01 Statement of capital following an allotment of shares on 16 October 2017
  • GBP 102,442.465401
  • ANNOTATION Clarification a second filed SH01 was registered on 13/08/2020
05 Feb 2018 SH01 Statement of capital following an allotment of shares on 19 May 2017
  • GBP 102,442.465401
  • ANNOTATION Clarification a second filed SH01 was registered on 13/08/2020
05 Feb 2018 CS01 Confirmation statement made on 23 October 2017 with updates
  • ANNOTATION Clarification a second filed CS01 (Statement of capital change) was registered on 01/09/2020.